Home / Market News / $RDHL

$RDHL news and market catalysts

The 5 most recent market catalysts affecting $RDHL, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

5 catalysts 1 high impact 5 bullish 0 bearish Pharmaceuticals
Sep 1, 2026 Corporate Catalyst Bullish Impact 75
RedHill Biopharma Announces Deal To Acquire Global Rebyota And U.S. Clenpiq Commercialization Rights From Ferring For $12M Upfront, Plus Milestones And Tiered Royalties
This headline represents a significant corporate catalyst for RedHill Biopharma, as it directly impacts their product portfolio and potential for future revenue growth. The acquisi…
Aug 31, 2026 Corporate Catalyst Bullish Impact 95
Redhill Biopharma Stock Doubles In One Session — Here's Why
Redhill Biopharma's divestment of Talicia to Apotex for $18 million upfront, with additional milestone payments, is a significant corporate catalyst. This transaction provides imme…
Aug 31, 2026 Corporate Catalyst Bullish Impact 75
Redhill Biopharma shares are trading higher after the company announced the divestment of its Talicia business to a subsidiary of Apotex Health.
This headline signifies a significant corporate catalyst for Redhill Biopharma. The divestment of its Talicia business is likely viewed positively by investors as it could reduce o…
Aug 31, 2026 Corporate Catalyst Bullish Impact 75
Redhill Biopharma Divests Talicia Business To Apotex Health Subsidiary For An Upfront Payment Of $18M Plus Up To An Additional $35M In Potential Sales-based Milestone Payments
Redhill Biopharma has announced the divestiture of its Talicia business to Apotex Health for an immediate $18 million and potential future payments. This transaction is a significa…
Jul 28, 2026 Corporate Catalyst Bullish Impact 75
RedHill Biopharma Says Ebola Outbreak Grows To 3221 Cases, 1407 Deaths; Opaganib Development And Partnership Talks Ongoing With African Medicines Agency, Ugandan Health Ministry
The primary impact of this headline is on RedHill Biopharma (RDHL). The ongoing development and partnership talks for Opaganib in the context of a growing Ebola outbreak present a …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.